1. Home
  2. EYPT vs IHRT Comparison

EYPT vs IHRT Comparison

Compare EYPT & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$0.43

Market Cap

273.3M

Sector

Industrials

ML Signal

HOLD

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

BUY

Current Price

$1.48

Market Cap

300.3M

ML Signal

BUY

Company Overview

Basic Information
Metric
EYPT
IHRT
Founded
1987
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Broadcasting
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
273.3M
300.3M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
EYPT
IHRT
Price
$0.43
$1.48
Analyst Decision
Buy
Sell
Analyst Count
13
4
Target Price
★ $25.91
$3.63
AVG Volume (30 Days)
★ 2.6M
627.3K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.19
EPS
N/A
★ N/A
Revenue
$7,539,000.00
★ $3,864,991,000.00
Revenue This Year
N/A
$7.20
Revenue Next Year
$967.16
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.27
52 Week Low
$2.93
$1.62
52 Week High
$19.11
$6.56

Technical Indicators

Market Signals
Indicator
EYPT
IHRT
Relative Strength Index (RSI) 15.08 18.08
Support Level N/A N/A
Resistance Level $3.57 $4.03
Average True Range (ATR) 0.20 0.12
MACD -0.04 -0.02
Stochastic Oscillator 0.67 2.19

Price Performance

Historical Comparison
EYPT
IHRT

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: